Cargando…

In Silico Insight into Potent of Anthocyanin Regulation of FKBP52 to Prevent Alzheimer's Disease

Alzheimer's disease (AD) is caused by the hyperphosphorylation of Tau protein aggregation. FKBP52 (FK506 binding protein 52) has been found to inhibit Tau protein aggregation. This study found six different kinds of anthocyanins that have high binding potential. After analyzing the docking posi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hung, Tzu-Chieh, Chang, Tung-Ti, Fan, Ming-Jen, Lee, Cheng-Chun, Chen, Calvin Yu-Chian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036721/ https://www.ncbi.nlm.nih.gov/pubmed/24899909 http://dx.doi.org/10.1155/2014/450592

Ejemplares similares

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
por: Zgajnar, Nadia R., et al.
Publicado: (2019)

Expression of FKBP52 in the ovaries of PCOS rats
por: Song, Shiyan, et al.
Publicado: (2019)

In Silico Investigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer's Disease
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer
por: Habara, Makoto, et al.
Publicado: (2022)

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells
por: Maeda, Keisuke, et al.
Publicado: (2021)

In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52
por: Mustafi, Sourajit M., et al.
Publicado: (2014)

Impact of FKBP52 on cell proliferation and hormone‐dependent cancers
por: Hanaki, Shunsuke, et al.
Publicado: (2023)

Control of Alzheimer's Amyloid Beta Toxicity by the High Molecular Weight Immunophilin FKBP52 and Copper Homeostasis in Drosophila
por: Sanokawa-Akakura, Reiko, et al.
Publicado: (2010)

FKBP52 in Neuronal Signaling and Neurodegenerative Diseases: A Microtubule Story
por: Chambraud, Béatrice, et al.
Publicado: (2022)

Investigation of Potent Lead for Acquired Immunodeficiency Syndrome from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Yu, et al.
Publicado: (2012)

Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014)

Studies of a co-chaperone of the androgen receptor, FKBP52, as candidate for hypospadias
por: Beleza-Meireles, Ana, et al.
Publicado: (2007)

Hsp90 can Accommodate the Simultaneous Binding of the FKBP52 and HOP Proteins
por: Hildenbrand, Zacariah L., et al.
Publicado: (2011)

Analysis of the cerebellar molecular stress response led to first evidence of a role for FKBP51 in brain FKBP52 expression in mice and humans
por: Herrmann, Leonie, et al.
Publicado: (2021)

Expression of PRB, FKBP52 and HB-EGF Relating with Ultrasonic Evaluation of Endometrial Receptivity
por: Wang, Ning, et al.
Publicado: (2012)

The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling
por: Storer Samaniego, Cheryl, et al.
Publicado: (2015)

Elevated FKBP52 expression indicates a poor outcome in patients with breast cancer
por: Hong, Chaoqun, et al.
Publicado: (2017)

The Hsp90-binding immunophilin FKBP52 enhances neurodifferentiation and neuroregeneration in murine models
por: Daneri-Becerra, Cristina, et al.
Publicado: (2021)

In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

The Inhibition of Folylpolyglutamate Synthetase (folC) in the Prevention of Drug Resistance in Mycobacterium tuberculosis by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Inactivation of ID4 promotes a CRPC phenotype with constitutive AR activation through FKBP52
por: Joshi, Jugal Bharat, et al.
Publicado: (2017)

FKBP52 overexpression accelerates hippocampal-dependent memory impairments in a tau transgenic mouse model
por: Criado-Marrero, Marangelie, et al.
Publicado: (2021)

Concomitant Neuronal Tau Deposition and FKBP52 Decrease Is an Early Feature of Different Human and Experimental Tauopathies
por: Meduri, Geri, et al.
Publicado: (2023)

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Insight into molecular dynamics simulation of BRAF(V600E) and potent novel inhibitors for malignant melanoma
por: Tang, Hsin-Chieh, et al.
Publicado: (2015)

Anthocyanins as Antidiabetic Agents—In Vitro and In Silico Approaches of Preventive and Therapeutic Effects
por: Oliveira, Hélder, et al.
Publicado: (2020)

Identification of Potent EGFR Inhibitors from TCM Database@Taiwan
por: Yang, Shun-Chieh, et al.
Publicado: (2011)

Finding Inhibitors of Mutant Superoxide Dismutase-1 for Amyotrophic Lateral Sclerosis Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice
por: Criado-Marrero, Marangelie, et al.
Publicado: (2021)

Lead Discovery for Alzheimer's Disease Related Target Protein RbAp48 from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Correction to: Hsp90 co‑chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild‑type mice
por: Criado-Marrero, Marangelie, et al.
Publicado: (2021)

FKBP51 and FKBP12.6—Novel and tight interactors of Glomulin
por: Hähle, Andreas, et al.
Publicado: (2019)

In Silico Investigation of Potential Src Kinase Ligands from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2012)

Lead Screening for CXCR4 of the Human HIV Infection Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tpfl4jfr44di446ut6cv33g7rn